Differences in treatment effect size between progression-free survival and overall survival in anti-PD-1/PD-L1 inhibitors-based trials in advanced NSCLC: a systematic review and meta-analysis

Zhou, ZR; Ren, SX; Chen, LX; Zhou, CC; Jiang, T

Jiang, T (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, 507 Zheng Min Rd, Shanghai 200433, Peoples R China.; Jiang, T (corresponding author), Tongji Univ, Sch Med, Thorac Canc Inst, 507 Zheng Min Rd, Shanghai 200433, Peoples R China.; Jiang, T (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Resp Res Inst, Dept Pulm Med, 180 Fenglin Rd, Shanghai 200032, Peoples R China.

TRANSLATIONAL LUNG CANCER RESEARCH, 2021; 10 (6): 2562

Abstract

Background: To investigate the differences in treatment effect sizes between progression-free survival (PFS) and overall survival (OS) in advanced non......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索